MemoMind Pharma is an affiliate of Austria-based Ebewe Pharmaceuticals. They tout that they have formulated MemoProve to enhance short-term memory in middle-aged and older adults by an average of 15 percent, which is equivalent to reversing 12 years of age-related memory decline. Ebewe Pharma was established in 1934 in Vienna, Austria. From 1956 to 2001, Ebewe acted as affiliates of the BASF Group and Abbott. In 2001, Ebewe Pharma once again became an independent, internationally active Austrian pharmaceutical company. They offer cutting-edge specialty pharmaceuticals in the areas neurology, oncology and immunology.